Format

Send to:

Choose Destination
See comment in PubMed Commons below
Trends Mol Med. 2013 Feb;19(2):74-82. doi: 10.1016/j.molmed.2012.10.011. Epub 2012 Dec 5.

Rho GTPases and their roles in cancer metabolism.

Author information

  • 1Department of Molecular Medicine, Cornell University, Ithaca, NY 14853-6401, USA.

Abstract

Recently, the small molecule 968 was found to block the Rho GTPase-dependent growth of cancer cells in cell culture and mouse xenografts, and when the target of 968 was found to be the mitochondrial enzyme glutaminase (GLS1), it revealed a surprising link between Rho GTPases and mitochondrial glutamine metabolism. Signal transduction via the Rho GTPases, together with NF-κB, appears to elevate mitochondrial glutaminase activity in cancer cells, thereby helping cancer cells satisfy their altered metabolic demands. Here, we review what is known about the mechanism of glutaminase activation in cancer cells, compare the properties of two distinct glutaminase inhibitors, and discuss recent findings that shed new light on how glutamine metabolism might affect cancer progression.

Copyright © 2012 Elsevier Ltd. All rights reserved.

PMID:
23219172
[PubMed - indexed for MEDLINE]
PMCID:
PMC3607349
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk